High pretreatment level of soluble interleukin-2 receptor is a robust prognostic factor in patients with follicular lymphoma treated with R-CHOP-like therapy
Blood Cancer Journal 7, e614 (September 2017). doi:10.1038/bcj.2017.96
Authors: Y Kusano, M Yokoyama, Y Terui, N Inoue, A Takahashi, H Yamauchi, N Tsuyama, N Nishimura, Y Mishima, K Takeuchi & K Hatake
from ! ORL Sfakianakis via paythelady.61 on Inoreader http://ift.tt/2fYSgNG
via IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου
Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,